Guangdong Marubi Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 1,059.1 million compared to CNY 815.57 million a year ago. Revenue was CNY 1,059.41 million compared to CNY 817.18 million a year ago.

Net income was CNY 130.68 million compared to CNY 117.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.33 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.33 compared to CNY 0.29 a year ago.